Levels of Synaptic Proteins in Brain and Neurofilament Light Chain in Cerebrospinal Fluid and Plasma of OVT73 Huntington's Disease Sheep Support a Prodromal Disease State

被引:1
|
作者
Sapp, Ellen [1 ]
Boudi, Adel [1 ]
Reid, Suzanne J. [2 ]
Trombetta, Bianca A. [3 ]
Kivisakk, Pia [3 ]
Taghian, Toloo [4 ,5 ]
Arnold, Steven E. [3 ]
Howland, David [6 ]
Gray-Edwards, Heather
Kegel-Gleason, Kimberly B. [1 ]
DiFiglia, Marian [1 ]
机构
[1] Harvard Med Sch, MassGeneral Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA
[2] Univ Auckland, Sch Biol Sci, Ctr Brain Res, Auckland, New Zealand
[3] Harvard Med Sch, Massachusetts Gen Hosp, Alzheimers Clin & Translat Res Unit, Dept Neurol, Boston, MA USA
[4] Univ Massachusetts, Dept Radiol, Chan Med Sch, Worcester, MA USA
[5] Univ Massachusetts, Horae Gene Therapy Ctr, Chan Med Sch, Worcester, MA USA
[6] CHDI Fdn, CHDI Management, New York, NY USA
关键词
Huntington's disease; HD sheep; caudate; putamen; synaptosomes; neurofilament light chain levels; cerebrospinal fluid; HUMAN MUTANT HUNTINGTIN; POLYGLUTAMINE REPEAT; ANIMAL-MODELS; MOUSE MODEL; EARLY MOTOR; CALMODULIN; PROTEOMICS; REVEALS; MICE;
D O I
10.3233/JHD-230590
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Synaptic changes occur early in patients with Huntington's disease (HD) and in mouse models of HD. An analysis of synaptic changes in HD transgenic sheep (OVT73) is fitting since they have been shown to have some phenotypes. They also have larger brains, longer lifespan, and greater motor and cognitive capacities more aligned with humans, and can provide abundant biofluids for in vivo monitoring of therapeutic interventions. Objective: The objective of this study was to determine if there were differences between 5- and 10-year-old OVT73 and wild-type (WT) sheep in levels of synaptic proteins in brain and in neurofilament light chain (NfL) in cerebrospinal fluid (CSF) and plasma. Methods: Mutant huntingtin (mHTT) and other proteins were measured by western blot assay in synaptosomes prepared from caudate, motor, and piriform cortex in 5-year-old and caudate, putamen, motor; and piriform cortex in 10-year-old WT and OVT73 sheep. Levels of NfL, a biomarker for neuronal damage increased in many neurological disorders including HD, were examined in CSF and plasma samples from 10-year-old WT and OVT73 sheep using the Simoa NfL Advantage kit. Results: Western blot analysis showed mHTT protein expression in synaptosomes from OVT73 sheep was 23% of endogenous sheep HTT levels at both ages. Significant changes were detected in brain levels of PDE10A, SCN4B, DARPP32, calmodulin, SNAP25, PSD95, VGLUT1, VAMP1, and Na+/K+-ATPase, which depended on age and brain region. There was no difference in NfL levels in CSF and plasma in OVT73 sheep compared to age-matched WT sheep. Conclusions: These results show that synaptic changes occur in brain of 5- and 10-year-old OVT73 sheep, but levels of NfL in biofluids are unaffected. Altogether, the data support a prodromal disease state in OVT73 sheep that involves the caudate, putamen and cortex.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 50 条
  • [41] Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice
    Caron, Nicholas S.
    Byrne, Lauren M.
    Lemarie, Fanny L.
    Bone, Jeffrey N.
    Aly, Amirah E. -E.
    Ko, Seunghyun
    Anderson, Christine
    Casal, Lorenzo L.
    Hill, Austin M.
    Hawellek, David J.
    McColgan, Peter
    Wild, Edward J.
    Leavitt, Blair R.
    Hayden, Michael R.
    TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01):
  • [42] Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease
    Parbo, Peter
    Madsen, Lasse Stensvig
    Ismail, Rola
    Zetterberg, Henrik
    Blennow, Kaj
    Eskildsen, Simon F.
    Vorup-Jensen, Thomas
    Brooks, David J.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [43] Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
    Peter Parbo
    Lasse Stensvig Madsen
    Rola Ismail
    Henrik Zetterberg
    Kaj Blennow
    Simon F. Eskildsen
    Thomas Vorup-Jensen
    David J. Brooks
    Alzheimer's Research & Therapy, 12
  • [44] Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer's Disease
    Yao, Weina
    Zhang, Xiao
    Zhao, Hui
    Xu, Yun
    Bai, Feng
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (02) : 505 - 518
  • [45] Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer's disease: A biochemical analysis in Pakistani population
    Ahmed, Tehniat Faraz
    Azmi, Muhammad Bilal
    Imtiaz, Fauzia
    Zaman, Uzma
    Ahmed, Affan
    Shahbaz, Naila
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (07) : 1202 - 1209
  • [46] Levels of the light subunit of neurofilament triplet protein in the cerebrospinal fluid from patients with Parkinson's disease treated with bilateral subthalamic nucleus stimulation
    Constantinescu, R.
    Rosengren, L.
    Johnels, B.
    Corneliusson, O.
    Zetterberg, H.
    Holmberg, B.
    MOVEMENT DISORDERS, 2009, 24 : S461 - S461
  • [47] Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease
    Kivisakk, Pia
    Carlyle, Becky C.
    Sweeney, Thadryan
    Quinn, James P.
    Ramirez, Christopher E.
    Trombetta, Bianca A.
    Mendes, Muriel
    Brock, Mary
    Rubel, Carrie
    Czerkowicz, Julie
    Graham, Danielle
    Arnold, Steven E.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [48] Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
    Pia Kivisäkk
    Becky C. Carlyle
    Thadryan Sweeney
    James P. Quinn
    Christopher E. Ramirez
    Bianca A. Trombetta
    Muriel Mendes
    Mary Brock
    Carrie Rubel
    Julie Czerkowicz
    Danielle Graham
    Steven E. Arnold
    Alzheimer's Research & Therapy, 14
  • [49] Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
    Gil-Perotin, Sara
    Castillo-Villalba, Jessica
    Cubas-Nunez, Laura
    Gasque, Raquel
    Hervas, David
    Gomez-Mateu, Josep
    Alcala, Carmen
    Perez-Miralles, Francisco
    Gascon, Francisco
    Dominguez, Jose Andres
    Casanova, Bonaventura
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [50] Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis
    Sako, Wataru
    Murakami, Nagahisa
    Izumi, Yuishin
    Kaji, Ryuji
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 352 (1-2) : 84 - 87